Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies
Paola G. Meregalli(Inserm), Arthur A.M. Wilde(Amsterdam Neuroscience), Connie R. Bezzina(Amsterdam Neuroscience), Jean‐Jacques Schott(Centre National de la Recherche Scientifique), Philippe Mabo, Frédéric Sacher(Centre Hospitalier Universitaire de Bordeaux), Florence Kyndt(Inserm), Hanno L. Tan(Netherlands Heart Institute), Hervé Le Marec(Centre National de la Recherche Scientifique), Juliette Albuisson(Délégation Paris 5), Zahurul A. Bhuiyan, Vincent Probst(Centre National de la Recherche Scientifique), Tamara T. Koopmann(University of Washington), Michael W.T. Tanck(Amsterdam UMC Location University of Amsterdam)
Cited by 249
Related Papers
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Genotype-Phenotype Correlation in the Long-QT Syndrome
|Circulation|2001|1.8k
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
|Heart Rhythm|2011|1.5k